Indian Govt Nixes Biotech Loan Saying Foreign-Controlled Companies Disqualified
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - The department of biotechnology under India's Ministry of Science and Technology has declined to advance a financial loan to Hyderabad-based biotechnology firm Shantha Biotech. Shantha Biotech had sought financial assistance for research on an undisclosed biotech drug and the financial loan was seen as a crucial step to speed up research
You may also be interested in...
Indian Vaccine Exports May Halt If Central Authority Does Not Comply With GMP Norms
MUMBAI - Large vaccine manufacturers in India may not be able to export their key products for long, nor can they cater to domestic demand, as the apex testing laboratory for vaccines - the Central Research Institute - has been de-recognized from doing such tests by the Drug Controller General of India.
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).